A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Artios Pharma Ltd
Frontier Medicines Corporation
Beijing Biotech
GI Innovation, Inc.
Hoffmann-La Roche
Merck Sharp & Dohme LLC
PMV Pharmaceuticals, Inc
Crinetics Pharmaceuticals Inc.
Verastem, Inc.
Ipsen
Pfizer
Eikon Therapeutics
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc.
Crescent Biopharma, Inc.
Aulos Bioscience, Inc.
Incyte Corporation
ModernaTX, Inc.
ALX Oncology Inc.
DualityBio Inc.
Ascendis Pharma A/S
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Tyra Biosciences, Inc
Daiichi Sankyo
Pfizer
Hoffmann-La Roche
Suzhou Transcenta Therapeutics Co., Ltd.
Regeneron Pharmaceuticals
VM Oncology, LLC
Takeda
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Novelwise Pharmaceutical Corporation
AstraZeneca
Transgene
Spago Nanomedical AB
Turning Point Therapeutics, Inc.
BioInvent International AB
Sotio Biotech Inc.
Revolution Medicines, Inc.
Novartis
Nuvalent Inc.
Vedanta Biosciences, Inc.
Eisai Inc.
Nuvalent Inc.
Incyte Corporation
Artios Pharma Ltd
Deciphera Pharmaceuticals, LLC